COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 1307: Articles 13061-13070  | Next

AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
Loo, Y.-M., McTamney, P. M., Arends, R. H., Gasser, R. A., Abram, M. E., Aksyuk, A., Diallo, S., Flores, D. J., Kelly, E. J., Ren, K., Roque, R., Rosenthal, K., Streicher, K., Tuffy, K. M., Bond, N. J., Cornwell, O., Bouquet, J., Cheng, L. I., Dunyak, J., Huang, Y., Rosenbaum, A. I., Andersen, H., Carnahan, R. H., Crowe, J. E., Kuehne, A. I., Herbert, A. S., Dye, J. M., Bright, H., Kallewaard, N. L., Pangalos, M. N., Esser, M. T.
10.1101/2021.08.30.21262666 — Posted: 2021-08-31
The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis
Jain, V., Lorgelly, P.
10.1101/2021.08.30.21262821 — Posted: 2021-08-31
The emergence of SARS-CoV-2 variants of concern is driven by acceleration of the evolutionary rate
Tay, J. H., Porter, A. F., Wirth, W., Duchene, S.
10.1101/2021.08.29.21262799 — Posted: 2021-08-31 Discussion: Onsite
Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine
Patalon, T., Gazit, S., Pitzer, V. E., Prunas, O., Warren, J. L., Weinberger, D. M.
10.1101/2021.08.29.21262792 — Posted: 2021-08-31
Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination
Truelove, S., Smith, C. P., Qin, M., Mullany, L. C., Borchering, R. K., Lessler, J., Shea, K., Howerton, E., Contamin, L., Levander, J., Salerno, J., van Panhuis, W., Hochheiser, H., Kinsey, M., Tallaksen, K., Wilson, S., Shin, L., Rainwater-Lovett, K., Lemaitre, J. C., Dent, J., Kaminsky, J., Lee, E. C., Perez-Saez, J., Hill, A., Karlen, D., Chinazzi, M., Davis, J. T., Mu, K., Xiong, X., Pastore y Piontti, A., Vespignani, A., Srivastava, A., Porebski, P., Venkatramanan, S., Adiga, A., Lewis, B., Klahn, B., Outten, J., Schlitt, J., Corbett, P., Telionis, P. A., Wang, L., Peddireddy, A. S., Hurt, B., Chen, J., Vullikanti, A., Marathe, M., Hoops, S., Bhattacharya, P., Machi, D., Chen, S., Paul, R., Janies, D., Thill, J.-C., Galanti, M., Yamana, T., Pei, S., Shaman, J., Reich, N. G., Healy, J. M., Slayton, R. B., Biggerstaff, M., Johansson, M. A., Runge, M. C., Viboud, C.
10.1101/2021.08.28.21262748 — Posted: 2021-08-31 Discussion: Onsite
Real-world evaluation of AI driven COVID-19 triage for emergency admissions: External validation & operational assessment of lab-free and high-throughput screening solutions
Soltan, A. A., Yang, J., Pattanshetty, R., Novak, A., Rohanian, O., Beer, S., Soltan, M. A., Thickett, D. R., Fairhead, R., CURIAL Translational Collaborative, , Zhu, T., Eyre, D. W., Clifton, D. A.
10.1101/2021.08.24.21262376 — Posted: 2021-08-31
Hybrid immunity versus vaccine-induced immunity against SARS CoV2 in Patients with Autoimmune Rheumatic Diseases
Shenoy, P., Ahmed, S., Paul, A., Cherian, S., Umesh, R., Shenoy, V., Vijayan, A., Babu, S., S, N., Thambi, A.
10.1101/2021.08.26.21258418 — Posted: 2021-08-31
Spatial equity of COVID-19 vaccination services in Aotearoa
Whitehead, J., Atatoa Carr, P., Scott, N., Lawrenson, R.
10.1101/2021.08.26.21262647 — Posted: 2021-08-31
COVID-19 vaccine hesitancy among Algerian medical students: a cross-sectional study in five universities.
Kerdoun, M. a., Henni, H. A., Yamoun, A., Rahmani, A., Kerdoun, R. M., Elouar, N.
10.1101/2021.08.29.21261803 — Posted: 2021-08-31
Prediction of vaccine efficacy of the Delta variant
Chen, X., Azman, A. S., Lu, W., Sun, R., Zheng, N., Ge, S., Deng, X., Yang, J., Leung, D., Yu, H.
10.1101/2021.08.26.21262699 — Posted: 2021-08-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).